Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Expenditure ₹252 Cr₹241 Cr₹11,780,424 Cr₹109 Cr₹109 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹252 Cr based on Mar2024 Consolidated results.
Year Total Expenditure
Mar2024₹252 Cr
Mar2023₹241 Cr
Mar2022₹11,780,424 Cr
Mar2013₹109 Cr
Mar2012₹109 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2024 ₹252 Cr
4.66
Mar2023 ₹241 Cr
-100.00
Mar2022 ₹11,780,424 Cr
10,783,686.36
Mar2013 ₹109 Cr
0.00
Mar2012 ₹109 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹346.1 Cr 3.8% -5.1% -11.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹17,556.0 Cr -1.8% -10% 72% Stock Analytics
KAVERI SEED COMPANY ₹4,564.2 Cr 6.1% 4.7% 42.6% Stock Analytics
VENKYS (INDIA) ₹2,399.5 Cr -1% 0.7% -14.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,518.8 Cr -2.3% -10.8% -36.8% Stock Analytics
TIERRA AGROTECH ₹402.6 Cr 2.3% 1.4% -34.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.8%

-5.1%

-11.5%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses